GV
Biotech Investor · 18 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Blank Bio | platform | — | Genetic Diseases, Oncology |
| Volastra Therapeutics | preclinical | — | Oncology, Genetics & Genomics |
| Rome Therapeutics | preclinical | — | Oncology, Immunology |
| Areteia Therapeutics | phase-3 | — | Respiratory, Immunology |
| Rezo Therapeutics | preclinical | — | Oncology |
| Clear Labs | Commercial | — | Oncology, Infectious Disease |
| Leyden Labs | Phase 1 | — | Infectious Disease, Respiratory Diseases |
| Cardurion Pharmaceuticals | Phase 2 | — | Cardiovascular, Heart Failure |
| IDRx, Inc. | phase-1 | — | Oncology |
| Seismic Therapeutic | preclinical | — | Immunology, Autoimmune Diseases |
| Obsidian Therapeutics | phase-1 | — | Oncology |
| NeuroDx | commercial | — | Neuroscience, Diagnostics |
| GenomeAI | platform | — | Genetics & Genomics, Diagnostics |
| Aera Therapeutics | preclinical | — | Gene Therapy, Rare Diseases |
| ImmunoVax | phase-2 | — | Oncology, Immunology |
| CellForge | phase-2 | — | Oncology, Immunology |
| Odyssey Therapeutics | phase-1 | — | Oncology, Immunology |
| LifeMine Therapeutics | preclinical | — | Oncology, Immunology |